Revenue Breakdown
Composition ()
No data
Revenue Streams
Waldencast PLC (WALD) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Medical, accounting for 72.6% of total sales, equivalent to $44.10M. Other significant revenue streams include Clinical and Other. Understanding this composition is critical for investors evaluating how WALD navigates market cycles within the Miscellaneous Specialty Retailers industry.
Profitability & Margins
Evaluating the bottom line, Waldencast PLC maintains a gross margin of 69.91%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -21.44%, while the net margin is -140.03%. These profitability ratios, combined with a Return on Equity (ROE) of -36.11%, provide a clear picture of how effectively WALD converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, WALD competes directly with industry leaders such as SLSN and YSG. With a market capitalization of $223.12M, it holds a significant position in the sector. When comparing efficiency, WALD's gross margin of 69.91% stands against SLSN's 23.09% and YSG's 78.17%. Such benchmarking helps identify whether Waldencast PLC is trading at a premium or discount relative to its financial performance.
